EndoSonics of Rancho Cordova, CA, announced this month an agreement with Jomed of Helsingborg, Sweden, to develop an intravascular ultrasound-guided stent delivery system together. The new system will integrate EndoSonics’ electronic imaging
EndoSonics of Rancho Cordova, CA, announced this month an agreement with Jomed of Helsingborg, Sweden, to develop an intravascular ultrasound-guided stent delivery system together. The new system will integrate EndoSonics electronic imaging catheter with Jomeds stent and balloon devices. The two firms hope their combined product will decrease post-angioplasty complications and streamline interventional procedures. Jomed anticipates marketing the device in early 1999, pending CE Mark approval.
In other EndoSonics news, the company announced that it has agreed to a five-year hiatus in its intellectual property claim litigation with Intravascular Research of the U.K. The temporary truce includes closing a Delaware lawsuit between the companies involving patent infringement disputes.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.